Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Green

Showing results (351-360 of 433) with videos related to

Pageof 44
Sort By:
Journal of Dual Diagnosis|April 28, 2015
A randomized trial of clozapine vs. other antipsychotics for cannabis use disorder in patients with schizophreniaMary F Brunette, Ree Dawson, Christopher D O'Keefe, et al.
Biological Psychiatry|September 22, 2001
Concurrent validation of schizotaxia: a pilot studyW S Stone, S V Faraone, L J Seidman, et al.
Journal of Hazardous Materials|February 9, 2011
Use of biogenic and abiotic elemental selenium nanospheres to sequester elemental mercury released from mercury contaminated museum specimensJ W Fellowes, R A D Pattrick, D I Green, et al.
Neurosurgical Focus|August 3, 2010
Deep brain stimulation of the nucleus accumbens reduces alcohol intake in alcohol-preferring ratsMichael B Henderson, Alan I Green, Perry S Bradford, et al.
Schizophrenia Bulletin|January 29, 2019
Potent Dopamine D2 Antagonists Block the Reward-Enhancing Effects of Nicotine in Smokers With SchizophreniaAlexis E Whitton, Alan I Green, Diego A Pizzagalli, et al.
Psychopharmacology|June 5, 2004
Effects of pharmacological doses of 2-deoxyglucose on plasma catecholamines and glucose levels in patients with schizophreniaIgor Elman, David Rott, Alan I Green, et al.
Schizophrenia Research|June 2, 2005
Clozapine action on auditory P3 response in schizophreniaMargaret A Niznikiewicz, Jayendra K Patel, Robert McCarley, et al.
Biopharmaceutics & Drug Disposition|May 1, 1997
Pharmacokinetics of MDL 26479, a novel benzodiazepine inverse agonist, in normal volunteersD K Robbins, S J Hutcheson, T D Miller, et al.
Journal of Substance Abuse Treatment|January 17, 2015
Treating tobacco use disorder in pregnant women in medication-assisted treatment for an opioid use disorder: a systematic reviewSarah C Akerman, Mary F Brunette, Alan I Green, et al.
Annals of Internal Medicine|June 1, 1974
Preferential cutaneous infiltration by neoplastic thymus-derived lymphocytes. Morphologic and functional studiesR L Edelson, C H Kirkpatrick, E M Shevach, et al.
Pageof 44

Showing results (351-360 of 433) with videos related to

Sort By:
Pageof 44
Journal of Dual Diagnosis|April 28, 2015
A randomized trial of clozapine vs. other antipsychotics for cannabis use disorder in patients with schizophreniaMary F Brunette, Ree Dawson, Christopher D O'Keefe, et al.
Biological Psychiatry|September 22, 2001
Concurrent validation of schizotaxia: a pilot studyW S Stone, S V Faraone, L J Seidman, et al.
Journal of Hazardous Materials|February 9, 2011
Use of biogenic and abiotic elemental selenium nanospheres to sequester elemental mercury released from mercury contaminated museum specimensJ W Fellowes, R A D Pattrick, D I Green, et al.
Neurosurgical Focus|August 3, 2010
Deep brain stimulation of the nucleus accumbens reduces alcohol intake in alcohol-preferring ratsMichael B Henderson, Alan I Green, Perry S Bradford, et al.
Schizophrenia Bulletin|January 29, 2019
Potent Dopamine D2 Antagonists Block the Reward-Enhancing Effects of Nicotine in Smokers With SchizophreniaAlexis E Whitton, Alan I Green, Diego A Pizzagalli, et al.
Psychopharmacology|June 5, 2004
Effects of pharmacological doses of 2-deoxyglucose on plasma catecholamines and glucose levels in patients with schizophreniaIgor Elman, David Rott, Alan I Green, et al.
Schizophrenia Research|June 2, 2005
Clozapine action on auditory P3 response in schizophreniaMargaret A Niznikiewicz, Jayendra K Patel, Robert McCarley, et al.
Biopharmaceutics & Drug Disposition|May 1, 1997
Pharmacokinetics of MDL 26479, a novel benzodiazepine inverse agonist, in normal volunteersD K Robbins, S J Hutcheson, T D Miller, et al.
Journal of Substance Abuse Treatment|January 17, 2015
Treating tobacco use disorder in pregnant women in medication-assisted treatment for an opioid use disorder: a systematic reviewSarah C Akerman, Mary F Brunette, Alan I Green, et al.
Annals of Internal Medicine|June 1, 1974
Preferential cutaneous infiltration by neoplastic thymus-derived lymphocytes. Morphologic and functional studiesR L Edelson, C H Kirkpatrick, E M Shevach, et al.
Pageof 44